PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-41.24%
Negative revenue growth while ANO.AX stands at 62.13%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-44.89%
Negative gross profit growth while ANO.AX is at 251.94%. Joel Greenblatt would examine cost competitiveness or demand decline.
-73.94%
Negative EBIT growth while ANO.AX is at 155.25%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-86.49%
Negative operating income growth while ANO.AX is at 648.74%. Joel Greenblatt would press for urgent turnaround measures.
-69.08%
Negative net income growth while ANO.AX stands at 161.71%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-70.00%
Negative EPS growth while ANO.AX is at 161.29%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-70.00%
Negative diluted EPS growth while ANO.AX is at 161.54%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.93%
Share count expansion well above ANO.AX's 0.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-2.64%
Reduced diluted shares while ANO.AX is at 0.46%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-185.61%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-187.98%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
170.06%
10Y revenue/share CAGR at 75-90% of ANO.AX's 223.10%. Bill Ackman would press for new markets or product lines to narrow the gap.
-15.95%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
39.74%
3Y revenue/share CAGR above 1.5x ANO.AX's 6.96%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-428.17%
Negative 10Y OCF/share CAGR while ANO.AX stands at 77.99%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-180.20%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-72.79%
Negative 3Y OCF/share CAGR while ANO.AX stands at 878.66%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
498.00%
Below 50% of ANO.AX's 4293.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-40.20%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
99.33%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
935.04%
10Y equity/share CAGR 1.25-1.5x ANO.AX's 813.84%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
82.81%
5Y equity/share CAGR above 1.5x ANO.AX's 53.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
85.42%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.07%
AR growth is negative/stable vs. ANO.AX's 53.52%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.58%
We show growth while ANO.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.85%
Negative asset growth while ANO.AX invests at 3.20%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
8.13%
BV/share growth above 1.5x ANO.AX's 2.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
14.17%
We have some new debt while ANO.AX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-12.77%
We cut SG&A while ANO.AX invests at 14.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.